| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 59.3052 | 64 |
| GSM780708 | Untreated after 4 days (C2_1) | 56.6523 | 62 |
| GSM780709 | Untreated after 4 days (C3_1) | 64.9097 | 67 |
| GSM780719 | Untreated after 4 days (C1_2) | 49.1316 | 46 |
| GSM780720 | Untreated after 4 days (C2_2) | 58.1161 | 63 |
| GSM780721 | Untreated after 4 days (C3_2) | 56.1919 | 61 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 59.8152 | 64 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 57.2905 | 62 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 64.0054 | 67 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 61.0867 | 65 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 59.9145 | 64 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 69.6466 | 69 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 72.0297 | 70 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 60.9254 | 65 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 65.6972 | 67 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 59.1106 | 64 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 63.8297 | 67 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 64.4091 | 67 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 58.9918 | 64 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 57.2529 | 62 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 64.8291 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 43.5565 | 20 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 58.9979 | 64 |